Monogram Technologies Inc. (MGRM) - Dilution Analysis

POS AM filing: This POS AM filing registers the resale of 6,243,974 shares of common stock by selling stockholders.

10-Q filing | 40.6M shares outstanding

8-K filing: The company filed a Certificate of Designation for Series E Redeemable Perpetual Preferred Stock, authorizing 35,000 shares, ranking senior to common stock and junior to future senior securities, convertible into common stock after July 1, 2026, and redeemable upon certain events.

10-Q filing | 35.2M shares outstanding

10-K filing | 32.6M shares outstanding

8-K filing: Certain related parties of the Company, including the CFO, purchased 480,767 shares of common stock totaling approximately $1 million on November 25, 2024. ($1.0M proceeds)

10-Q filing | 32.2M shares outstanding

8-K filing: The Company closed its Series D Preferred Stock Offering on October 1, 2024, selling 5,790,479 units, each consisting of one share of Series D Preferred Stock and one common stock purchase warrant, for net proceeds of approximately $11.7 million. ($11.7M proceeds)

10-Q filing | 31.6M shares outstanding

8-K filing: Monogram Technologies Inc. entered into a selling agency agreement with Digital Offering LLC for a best efforts offering of up to 4,444,445 units, each consisting of Series D Preferred Stock and a common stock purchase warrant.

S-3 filing: Monogram Technologies Inc. is filing an S-3 to offer and sell shares of common stock, preferred stock, warrants and rights to purchase common stock, preferred stock or units, as well as units that include any of these securities, with an aggregate offering price of up to $100,000,000.

10-Q filing | 31.5M shares outstanding

POS AM filing: POS AM filing regarding the offering of common stock through an equity line purchase agreement with B. Riley Principal Capital II, with Northland Securities, Inc. acting as the qualified independent underwriter.

8-K filing: Monogram Orthopaedics Inc. issued 256,026 shares of common stock for gross proceeds of $887,831 pursuant to a Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC. ($0.89M proceeds)

10-K filing | 31.3M shares outstanding

10-Q filing | 29.3M shares outstanding

8-K filing: Pro-Dex exercised warrants for 1,828,551 shares of Monogram Orthopaedics Inc.'s common stock at $0.68360138711 per share, resulting in $1,250,000 in proceeds. ($1.25M proceeds)

S-1/A filing: This S-1/A filing registers for resale 6,500,000 shares of common stock, including 45,252 commitment shares, that may be issued to B. Riley Principal Capital II under a purchase agreement, with a total commitment of up to $20,000,000.

10-Q filing | 29.3M shares outstanding

S-1 filing: This S-1 filing registers for resale 6,500,000 shares of common stock related to a purchase agreement with B. Riley Principal Capital II, where B. Riley has committed to purchase up to $20,000,000 of shares.

8-K filing: Monogram Orthopaedics Inc. entered into a Common Stock Purchase Agreement with B. Riley Principal Capital II, potentially allowing the company to sell up to $20,000,000 of newly issued common stock, or 5,847,725 shares, subject to certain conditions and limitations. ($0.2M proceeds)

10-Q filing | 29.3M shares outstanding